Sepracor taps Adams as CEO

Sepracor named Adrian Adams CEO, replacing Timothy Barberich, who was elected executive chairman of the company’s board of directors.
Adams appointment had been anticipated since his hiring as COO on March 1.
Adams, who will retain title of president, was previously CEO at Kos Pharmaceuticals from 2002 until the acquisition of the company by Abbott Laboratories in December 2006 for $3.7 billion.
Adams is a 30-year veteran of the pharmaceutical industry with experience in national and international product marketing, R&D, sales, business development and general management with companies including ICI, SmithKline Beecham and Novartis.